| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 249.77B | 252.33B | 250.60B | 242.43B | 239.29B | 223.28B |
| Gross Profit | 97.23B | 95.09B | 92.23B | 92.89B | 91.77B | 87.05B |
| EBITDA | 5.62B | 9.34B | 9.11B | 9.72B | 12.97B | 9.25B |
| Net Income | -1.53B | -2.16B | 971.00M | 2.59B | 5.40B | 3.84B |
Balance Sheet | ||||||
| Total Assets | 212.61B | 206.00B | 205.57B | 210.40B | 211.78B | 208.87B |
| Cash, Cash Equivalents and Short-Term Investments | 22.07B | 15.81B | 19.86B | 24.94B | 32.89B | 39.89B |
| Total Debt | 7.26B | 6.29B | 8.40B | 10.96B | 13.05B | 15.59B |
| Total Liabilities | 91.22B | 87.68B | 83.44B | 85.58B | 89.21B | 90.16B |
| Stockholders Equity | 121.00B | 118.16B | 121.72B | 124.45B | 122.36B | 118.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.31B | 5.31B | -2.86B | 1.38B | -2.78B |
| Operating Cash Flow | 0.00 | 9.68B | 12.06B | 4.27B | 7.02B | 2.23B |
| Investing Cash Flow | 0.00 | -11.26B | -9.60B | -8.04B | -5.48B | -5.16B |
| Financing Cash Flow | 0.00 | -3.32B | -7.53B | -4.14B | -7.91B | -2.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥44.74B | 14.03 | ― | 2.19% | 15.14% | 17.01% | |
68 Neutral | ¥253.45B | 18.37 | 10.61% | 1.81% | 7.78% | 20.67% | |
63 Neutral | ¥75.36B | 21.84 | ― | 2.11% | 4.97% | -22.34% | |
62 Neutral | ¥89.05B | 5.52 | 6.96% | 2.98% | 3.43% | 31.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥46.69B | -3.39 | ― | 3.31% | 0.69% | -377.37% | |
43 Neutral | ¥10.35B | 19.13 | ― | 3.08% | 2.51% | -235.45% |